- Home
- ARI vs DYN Comparison
ARI vs DYN Comparison
Compare ARI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARI
- DYN
- Stock Information
- Founded
- ARI 2009
- DYN 1984
- Country
- ARI United States
- DYN United States
- Employees
- ARI N/A
- DYN N/A
- Industry
- ARI Real Estate Investment Trusts
- DYN Medicinal Chemicals and Botanical Products
- Sector
- ARI Real Estate
- DYN Health Care
- Exchange
- ARI Nasdaq
- DYN Nasdaq
- Market Cap
- ARI 1.1B
- DYN 1.3B
- IPO Year
- ARI 2009
- DYN 2020
- Fundamental
- Price
- ARI $9.95
- DYN $14.70
- Analyst Decision
- ARI Hold
- DYN Strong Buy
- Analyst Count
- ARI 5
- DYN 13
- Target Price
- ARI $9.83
- DYN $45.92
- AVG Volume (30 Days)
- ARI 959.0K
- DYN 2.0M
- Earning Date
- ARI 04-24-2025
- DYN 05-08-2025
- Dividend Yield
- ARI 10.05%
- DYN N/A
- EPS Growth
- ARI N/A
- DYN N/A
- EPS
- ARI N/A
- DYN N/A
- Revenue
- ARI $276,844,000.00
- DYN N/A
- Revenue This Year
- ARI $32.11
- DYN N/A
- Revenue Next Year
- ARI $19.41
- DYN N/A
- P/E Ratio
- ARI N/A
- DYN N/A
- Revenue Growth
- ARI 104.64
- DYN N/A
- 52 Week Low
- ARI $7.70
- DYN $6.36
- 52 Week High
- ARI $11.20
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- ARI 60.29
- DYN 72.20
- Support Level
- ARI $9.68
- DYN $13.14
- Resistance Level
- ARI $9.92
- DYN $12.34
- Average True Range (ATR)
- ARI 0.17
- DYN 0.79
- MACD
- ARI -0.01
- DYN 0.23
- Stochastic Oscillator
- ARI 95.69
- DYN 91.82
About ARI Apollo Commercial Real Estate Finance Inc
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.